| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Qvt Financial LP | 65.79M (19.37%) | 0.00 Increased by 0.00% | Dec 31, 24 |
| 2 | SB INVESTMENT ADVISERS (UK) LTD | 61.85M (18.21%) | -204.82K Decreased by -0.33% | Mar 31, 25 |
| 3 | FMR Inc | 51.67M (15.21%) | 2.36M Increased by +4.58% | Mar 31, 25 |
| 4 | Viking Global Investors LP | 46.01M (13.54%) | -1.80M Decreased by -3.90% | Mar 31, 25 |
| 5 | BlackRock Inc | 41.66M (12.26%) | -498.04K Decreased by -1.20% | Mar 31, 25 |
| 6 | Vanguard Group Inc | 40.77M (12.00%) | -3.32M Decreased by -8.14% | Mar 31, 25 |
| 7 | Morgan Stanley - Brokerage Accounts | 35.93M (10.58%) | 1.31M Increased by +3.65% | Mar 31, 25 |
| 8 | State Street Corp | 18.86M (5.55%) | -1.94M Decreased by -10.29% | Mar 31, 25 |
| 9 | Rubric Capital Management LP | 17.77M (5.23%) | -2.23M Decreased by -12.57% | Mar 31, 25 |
| 10 | State Street Corporation | 17.15M (5.05%) | 3.43M Increased by +19.97% | Mar 31, 24 |
| 11 | Wellington Management Company LLP | 13.64M (4.02%) | -1.20M Decreased by -8.82% | Dec 31, 23 |
| 12 | Patient Square Capital | 12.48M (3.67%) | 0.00 Increased by 0.00% | Mar 31, 25 |
| 13 | T. Rowe Price Investment Management,Inc. | 10.65M (3.13%) | 10.65M Increased by +100.00% | Sep 30, 23 |
| 14 | Two Seas Capital LP | 10.14M (2.98%) | -31.50K Decreased by -0.31% | Mar 31, 25 |
| 15 | Amvescap Plc. | 9.52M (2.80%) | 3.16M Increased by +33.21% | Dec 31, 24 |
| 16 | Geode Capital Management, LLC | 7.97M (2.35%) | 195.55K Increased by +2.45% | Mar 31, 25 |
| 17 | Baker Bros Advisors LP | 7.41M (2.18%) | -179.19K Decreased by -2.42% | Mar 31, 24 |
| 18 | Farallon Capital Management, L.L.C. | 7.34M (2.16%) | 3.48M Increased by +47.47% | Dec 31, 23 |
| 19 | Citadel Advisors Llc | 5.93M (1.75%) | 4.00M Increased by +67.54% | Sep 30, 24 |
| 20 | Adage Capital Partners Gp LLC | 5.72M (1.68%) | -34.75K Decreased by -0.61% | Dec 31, 24 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity Growth Compy Commingled Pl S | 23.60M (6.95%) | 35.20K Increased by +0.15% | Mar 31, 25 |
| 2 | Fidelity Growth Compy Commingled Pl O | 21.15M (6.23%) | 439.20K Increased by +2.08% | Aug 31, 24 |
| 3 | Fidelity Growth Company Fund | 16.68M (4.91%) | 42.30K Increased by +0.25% | Mar 31, 25 |
| 4 | Vanguard US Total Market Shares ETF | 14.26M (4.20%) | 14.26M Increased by +100.00% | Sep 30, 24 |
| 5 | Vanguard Total Stock Mkt Idx Inv | 13.75M (4.05%) | 125.92K Increased by +0.92% | Apr 30, 25 |
| 6 | iShares Core S&P Mid-Cap ETF | 13.63M (4.01%) | -43.96K Decreased by -0.32% | Apr 30, 25 |
| 7 | Fidelity® Growth Company | 10.84M (3.19%) | 288.60K Increased by +2.66% | Nov 30, 23 |
| 8 | Vanguard Small Cap Index | 10.75M (3.16%) | 56.85K Increased by +0.53% | Apr 30, 25 |
| 9 | Vanguard Health Care Inv | 9.57M (2.82%) | 0.00 Increased by 0.00% | Dec 31, 23 |
| 10 | Vanguard Institutional Extnd Mkt Idx Tr | 6.52M (1.92%) | 7.78K Increased by +0.12% | Apr 30, 25 |
| 11 | Invesco S&P MidCap Quality ETF | 6.10M (1.80%) | 0.00 Increased by 0.00% | Apr 30, 25 |
| 12 | Vanguard Small Cap Growth Index Inv | 5.98M (1.76%) | -10.10K Decreased by -0.17% | Apr 30, 25 |
| 13 | SPDR® S&P Biotech ETF | 5.93M (1.74%) | -86.76K Decreased by -1.46% | Apr 30, 25 |
| 14 | Fidelity Growth Company K6 | 5.27M (1.55%) | 13.00K Increased by +0.25% | Mar 31, 25 |
| 15 | T. Rowe Price Mid-Cap Growth | 5.25M (1.55%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 16 | T. Rowe Price US Mid-Cap Growth Equity | 5.25M (1.55%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 17 | Fidelity® Select Biotechnology | 4.60M (1.35%) | 61.10K Increased by +1.33% | Nov 30, 23 |
| 18 | Fidelity Series Growth Company | 4.36M (1.28%) | 100.20K Increased by +2.30% | Mar 31, 25 |
| 19 | MS INVF US Advantage I | 3.77M (1.11%) | 0.00 Increased by 0.00% | Dec 31, 24 |
| 20 | MS INVF US Growth I | 3.65M (1.07%) | 14.10K Increased by +0.39% | Dec 31, 24 |